Aju Ib Investment Co., Ltd.

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001710065
Type: FundHoldings: 8Value: $84.0MLatest: 2025Q1

AJU IB Investment Co., Ltd. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 8 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-08
Total Holdings
8
Total Value
84044699
Accession Number
0001140361-25-012676
Form Type
13F-HR
Manager Name
Aju-Ib-Investment-Co
Data Enrichment
100% identified
8 identified0 unidentified

Holdings

8 positions • $84.0M total value
Manager:
Search and click to pin securities to the top
Arcellx, Inc.
Shares:1.0M
Value:$68.7M
% of Portfolio:81.8% ($68.7M/$84.0M)
Kymera Therapeutics, Inc.
Shares:457.1K
Value:$12.5M
% of Portfolio:14.9% ($12.5M/$84.0M)
Seer, Inc.
Shares:816.4K
Value:$1.4M
% of Portfolio:1.6% ($1.4M/$84.0M)
Rallybio Corp
Shares:754.7K
Value:$493.9K
% of Portfolio:0.6% ($493.9K/$84.0M)
Xilio Therapeutics, Inc.
Shares:667.7K
Value:$483.7K
% of Portfolio:0.6% ($483.7K/$84.0M)
Carisma Therapeutics Inc.
Shares:718.3K
Value:$222.7K
% of Portfolio:0.3% ($222.7K/$84.0M)
RAPT Therapeutics, Inc.
Shares:99.5K
Value:$121.4K
% of Portfolio:0.1% ($121.4K/$84.0M)
SUTRO BIOPHARMA, INC.
Shares:175.0K
Value:$113.9K
% of Portfolio:0.1% ($113.9K/$84.0M)